Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

29. August 2025 07:00 ET | Quelle: Alumis Inc.

Alumis to Participate in Upcoming September Investor Conferences

Alumis management will participate in several healthcare conference upcoming in September
13. August 2025 16:05 ET | Quelle: Alumis Inc.

Alumis Reports Second Quarter 2025 Financial Results and Provides Corporate Update

Alumis Reports Second Quarter 2025 Financial Results and Provides Corporate Update
24. Juli 2025 07:30 ET | Quelle: Alumis Inc.

Alumis Completes Patient Enrollment in the Global LUMUS Phase 2b Trial of ESK-001, a Next-Generation Oral TYK2 Inhibitor for the Treatment of Systemic Lupus Erythematosus

Alumis Completes Patient Enrollment in Global LUMUS Phase 2b Trial of ESK-001, Next-Generation Oral TYK2 Inhibitor for SLE, data in 3Q 2026
14. Juli 2025 16:05 ET | Quelle: Alumis Inc.

Alumis Announces the Promotion of Sanam Pangali to Chief Legal Officer and Corporate Secretary

Alumis Announces the Promotion of Sanam Pangali to Chief Legal Officer and Corporate Secretary
29. Mai 2025 16:15 ET | Quelle: Alumis Inc.

Alumis to Present at the Jefferies Global Healthcare Investor Conference

Alumis to present at Jefferies Global Healthcare Conference on June 4, 2025
29. Mai 2025 07:55 ET | Quelle: Alumis Inc.

Alumis Completes Enrollment of Pivotal Phase 3 ONWARD Clinical Program of Lead Candidate ESK-001, a Highly Selective, Next-Generation Oral TYK2 Inhibitor for the Treatment of Moderate-to-Severe Plaque Psoriasis

Alumis completed enrollment of Phase 3 ONWARD clinical program of ESK-001, a next-generation oral TYK2 inhibitor for moderate-to-severe plaque psoriasis
21. Mai 2025 09:10 ET | Quelle: Alumis Inc.

Alumis Completes Merger with ACELYRIN

Alumis Completes Merger with ACELYRIN
14. Mai 2025 16:05 ET | Quelle: Alumis Inc.

Alumis Reports First Quarter 2025 Financial Results and Highlights Recent Achievements

Alumis Reports First Quarter 2025 Financial Results and Highlights Recent Achievements
13. Mai 2025 13:00 ET | Quelle: Alumis Inc.

Alumis Stockholders Approve Merger with ACELYRIN

Alumis Stockholders Approve Merger with ACELYRIN
21. April 2025 06:30 ET | Quelle: Alumis Inc.

Alumis and ACELYRIN Announce Amended Merger Agreement

Alumis and ACELYRIN Announce Amended Merger Agreement

Nächste Seite